Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2021 | 2 |
2023 | 1 |
2024 | 2 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
What we should know about natural killer/T-cell lymphomas.
Hematol Oncol. 2019 Jun;37 Suppl 1:75-81. doi: 10.1002/hon.2588.
Hematol Oncol. 2019.
PMID: 31187536
Review.
Clinical efficacy and tumour microenvironment influence of decitabine plus R-CHOP in patients with newly diagnosed diffuse large B-Cell lymphoma: Phase 1/2 and biomarker study.
Zhang MC, Fang Y, Xu PP, Dong L, Shen R, Huang YH, Fu D, Yan ZX, Cheng S, Jiang XF, Song Q, He Y, Zhao Y, Lu M, Ye J, Liu F, Cheng L, Wang CF, Wang L, Zhao WL.
Zhang MC, et al.
Clin Transl Med. 2021 Dec;11(12):e584. doi: 10.1002/ctm2.584.
Clin Transl Med. 2021.
PMID: 34923760
Free PMC article.
No abstract available.
Item in Clipboard
Implication of immune cell signature of tumor microenvironment in diffuse large B-cell lymphoma.
Yu H, Fu D, Xu PP, Cheng S, Wang L, Zhang YZ, Zhao WL.
Yu H, et al.
Hematol Oncol. 2021 Dec;39(5):616-624. doi: 10.1002/hon.2905. Epub 2021 Jul 31.
Hematol Oncol. 2021.
PMID: 34331367
Item in Clipboard
Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma.
Shen R, Xu PP, Wang N, Yi HM, Dong L, Fu D, Huang JY, Huang HY, Janin A, Cheng S, Wang L, Zhao WL.
Shen R, et al.
Clin Transl Med. 2020 Nov;10(7):e221. doi: 10.1002/ctm2.221.
Clin Transl Med. 2020.
PMID: 33252851
Free PMC article.
Item in Clipboard
CD47 overexpression is related to tumour-associated macrophage infiltration and diffuse large B-cell lymphoma progression.
Shen YG, Ji MM, Yi HM, Shen R, Fu D, Cheng S, Huang CX, Wang L, Xu PP, Dou HJ, Zhao WL.
Shen YG, et al.
Clin Transl Med. 2024 Jan;14(1):e1532. doi: 10.1002/ctm2.1532.
Clin Transl Med. 2024.
PMID: 38193627
Free PMC article.
No abstract available.
Item in Clipboard
A novel SLC1A1-RIC1 fusion sensitive to asparaginase-based therapy in natural killer/T-cell lymphoma.
Xiong J, Zhao WL.
Xiong J, et al.
Br J Haematol. 2023 Nov;203(3):485-489. doi: 10.1111/bjh.19066. Epub 2023 Sep 1.
Br J Haematol. 2023.
PMID: 37658626
No abstract available.
Item in Clipboard
Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitor.
Shi ZY, Fang Y, Xu PP, Yi HM, Li JF, Dong Y, Zhu Y, Liu MK, Fu D, Wang S, Shi Q, Shen R, Zhong HJ, Wang CF, Cheng S, Wang L, Liu F, Zhao WL.
Shi ZY, et al.
Clin Transl Med. 2024 Jun;14(6):e1691. doi: 10.1002/ctm2.1691.
Clin Transl Med. 2024.
PMID: 38812093
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite